| Apr 26 | Apr 25 | Apr 24 | Apr 23 | Apr 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 178.56K | $ 144.38K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 69.04K | $ 41.92K | $ 0.00 | $ 0.00 | $ -467.57K |
| Operating Income | $ -838.05K | $ -828.78K | - | $ -49.06K | $ -818.00K |
| EBITDA | $ -838.05K | $ -781.40K | - | $ -49.06K | - |
| Net Income | $ -905.05K | $ -781.40K | $ -123.00 | $ -140.66K | $ -821.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.65K | $ 2.08K | $ 5.91K | $ 31.00 | $ 33.54K |
| Total Assets | $ 1.65K | $ 1.11M | $ 5.91K | $ 31.00 | $ 33.54K |
| Total Debt | $ 383.60K | $ 388.10K | $ 183.30K | $ 183.30K | $ 183.30K |
| Net Debt | $ 381.94K | $ 386.02K | $ 177.39K | $ 183.27K | $ 149.76K |
| Total Liabilities | $ 1.00M | $ 910.36K | $ 632.90K | $ 553.68K | $ 466.53K |
| Stockholders' Equity | $ -1.10M | $ 201.72K | $ -626.98K | $ -553.65K | $ -432.99K |
| Cash Flow | |||||
| Free Cash Flow | $ -300.43K | $ -746.24K | $ -62.69K | $ -53.51K | $ -116.72K |
| Operating Cash Flow | $ -300.43K | $ -746.24K | $ -62.69K | $ -53.51K | $ -116.72K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 300.00K | $ 742.40K | $ 35.00K | $ 20.00K | $ 150.00K |
BioQuest Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.